ATB200/AT2221
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ATB200/AT2221, covering 2023-09-11 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD) [Phase 3]